Hosted by the Canadian RNA Biomanufacturing Co-op

Building Academic-Industry Partnerships

Host: Kimberly Reid (OHRI)
Sponsored by: Canadian RNA Biomanufacturing Co-op (merging with The Society for RNA Therapeutics)
Support from: BioCanRx

Video found below.

Key Themes

Key Themes (Categorized)

1. Getting Started: Breaking into Industry Partnerships

  • Start with scientific alignment and mutual
  • Finding the right person is the biggest hurdle—requires persistence and repetition
  • Networking matters: conferences, informal conversations, ongoing engagement
  • Funding ecosystems are complex—understanding grants, cash vs. in-kind, incentives is a barrier
  • Mitacs and similar organizations can act as connectors/sounding boards

2. Building the Relationship (Not Just a Project)

  • Strong partnerships are relationship-driven, not transactional
  • Reputation = a long-term funding mechanism (easy to work with = repeat partnerships)
  • Avoid dependence on a single champion—engage multiple stakeholders
  • Start small → de-risk → scale up

3. Structuring a Successful Collaboration

  • Align early on:
    • IP (background vs. foreground)
    • Publication expectations
    • Roles and responsibilities
    • Reporting cadence
    • Commercialization pathways
  • Clear expectations + operational structure + communication framework are critical
  • Academic–industry projects are co-developed, not dictated

4. Where Partnerships Go Wrong

  • Mismatch between expectations and reality (scope, timelines, deliverables)
  • Timeline misalignment:
    • Industry = fiscal year cycles
    • Academia = grant and trainee timelines
  • Over-scoped projects vs. available talent (e.g., undergrad vs. postdoc capacity)
  • Rigidity vs. flexibility mismatch (industry vs. research exploration)

5. The Role of IP & Publishing

  • Tension exists but is often overstated
  • Start with smaller projects to build trust and avoid legal bottlenecks
  • Separate:
    • Background IP (protected)
    • Foreground IP (negotiated)
  • Publishing is increasingly valuable to both sides (including companies)

6. Value of Collaboration: Why It Works

  • Academia = fast experimentation, higher risk tolerance
  • Industry = focus on commercialization and scale
  • Trainees are a critical bridge (skills + talent pipeline)
  • Collaboration helps de-risk innovation before scaling

7. Commercialization & Translation Mindset

  • “Start with the end in mind” (manufacturability matters early)
  • Balance needed:
    • Academic freedom to explore
    • Industry need for scalable, reproducible solutions
  • Some transformative ideas may look unmanufacturable early—but still succeed

8. Workforce & Skills of the Future

  • Core skills:
    • Adaptability & “learning to learn”
    • Cross-sector communication
    • Critical thinking (especially in AI-driven workflows)
    • Delivering under commercial timelines
  • Internships are high-value: real-world training + talent pipeline